Malignancies in hepatitis C virus-positive and -negative kidney transplant recipients: A case-controlled study

Transplant Infectious Disease : an Official Journal of the Transplantation Society
Gaëlle DörrNassim Kamar

Abstract

Malignancies and lymphoma are common complications after kidney transplantation. However, no link has been made between the incidence of malignancies and hepatitis C virus (HCV) infection in this setting. This case-controlled study compared the incidence of malignancies, including lymphoma, between kidney transplant (KT) patients with or without HCV replication. A total of 99 HCV-positive RNA-positive KT patients were matched with 198 (1:2) anti-HCV-negative patients according to age, gender, and date of transplantation, and were followed for 145.8±78.4 months. During the follow-up period, 28 HCV-positive (28%) cases developed at least one cancer, and 64 (32%) patients developed cancer in the HCV-negative group (P=not significant [ns]). Survival without a cancer was similar between both groups. Thirteen HCV-positive patients (13%) developed at least one solid cancer vs 29 (15%) HCV-negative patients (P=ns). Survival without a solid cancer was similar between both groups. Three patients from the HCV-positive and 4 from the HCV-negative group developed a lymphoma. Only 2 patients from the HCV group died from hepatocellular carcinoma. Survival without a skin cancer was similar between both groups. Patient and death-censored graft ...Continue Reading

References

Jul 31, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J D Briggs
Apr 23, 2002·Clinical Transplantation·Marie K BreitenfeldtWolfgang H Grotz
Feb 27, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Bertram L KasiskeArthur J Matas
Apr 25, 2003·The New England Journal of Medicine·Sylvie EuvrardAlain Claudy
Jun 9, 2004·International Journal of Cancer. Journal International Du Cancer·Eric A EngelsPatricia Hartge
Jun 18, 2004·Kidney International·Mahendra L AgraharkarVahakn B Shahinian
Sep 17, 2004·Transplantation·Annette BruchfeldCarl-Gustaf Elinder
Dec 8, 2004·Journal of the American Society of Nephrology : JASN·John P FormanJulie Lin
May 13, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Fabrizio FabriziGareth Dulai
Jun 10, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Nassim KamarJacques Izopet
Sep 8, 2006·European Journal of Gastroenterology & Hepatology·Patrizia BurraSavina Maria Luciana Aversa
Nov 8, 2006·Gastroenterology·Alexandra NietersSilvia De Sanjosé
Sep 15, 2007·Autoimmunity Reviews·Dan-Avi LandauPatrice Cacoub
May 1, 2010·Journal of the American Society of Nephrology : JASN·Martin P GallagherAngela C Webster
Jun 20, 2012·Archives of Dermatology·Jo Leonardi-BeeFiona Bath-Hextall
Apr 6, 2013·Cancer·Erin C HallEric A Engels
Nov 21, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·N KamarL Alric
Nov 26, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D SawinskiR D Bloom

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.